License and purchase agreements.

No definition available.

Name:	imra_LicenseAndPurchaseAgreementsLineItems
Namespace Prefix:	imra_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Maximum development milestones payments due for licensed compounds.

+ References

No definition available.

+ Details

Name:	imra_MaximumDevelopmentMilestonesPaymentsDueForLicensedCompounds
Namespace Prefix:	imra_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Maximum development milestones payments due for other than licensed compounds.

+ References

No definition available.

+ Details

Name:	imra_MaximumDevelopmentMilestonesPaymentsDueForOtherThanLicensedCompounds
Namespace Prefix:	imra_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Milestone payment triggered under agreement.

+ References

No definition available.

+ Details

Name:	imra_MilestonePaymentTriggeredUnderAgreement
Namespace Prefix:	imra_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Milestones payments payable based on achievement of specified clinical and commercial sale milestones.

+ References

No definition available.

+ Details

Name:	imra_MilestonesPaymentsPayableBasedOnAchievementOfSpecifiedClinicalAndCommercialSaleMilestones
Namespace Prefix:	imra_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Notice period for agreement termination.

+ References

No definition available.

+ Details

Name:	imra_NoticePeriodForAgreementTermination
Namespace Prefix:	imra_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of outstanding shares issued as partial consideration for license.

+ References

No definition available.

+ Details

Name:	imra_PercentageOfOutstandingSharesIssuedAsPartialConsiderationForLicense
Namespace Prefix:	imra_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Upfront and ongoing milestone payments.

+ References

No definition available.

+ Details

Name:	imra_UpfrontAndOngoingMilestonePayments
Namespace Prefix:	imra_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_CommonStockSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=imra_LundbeckMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=imra_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=imra_ComplexaLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=imra_AssetPurchaseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

License and Purchase Agreements - Additional Information (Details) - USD ($)	1 Months Ended		12 Months Ended		69 Months Ended
	Oct. 31, 2020	Apr. 30, 2016	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2019
License And Purchase Agreements [Line Items]
Common stock, shares issued			26,287,264	17,548,263	26,287,264
Lundbeck \| Lundbeck Agreement
License And Purchase Agreements [Line Items]
Maximum development milestones payments due		$ 23,500,000
Maximum development milestones payments due for other than licensed product		$ 11,800,000
Upfront and ongoing milestone payments			$ 0	$ 0
Common stock, shares issued		167,523				443,271
Outstanding equity percentage pursuant to restricted stock agreement		8.00%
Notice period for agreement termination			180 days
Lundbeck \| Lundbeck Agreement \| Research and Development Expense
License And Purchase Agreements [Line Items]
Upfront and ongoing milestone payments					$ 1,800,000
Complexa ABC \| Complexa APA
License And Purchase Agreements [Line Items]
Milestone payment triggered under agreement.			$ 0		$ 0
Complexa ABC \| Complexa APA \| Maximum
License And Purchase Agreements [Line Items]
Milestones payments payable based on achievement of specified clinical and commercial sale milestones	$ 3,800,000
Complexa ABC \| Complexa APA \| Research and Development Expense
License And Purchase Agreements [Line Items]
One-time payment to acquire right, title and interest in and to certain assets	$ 100,000